This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Xun Zhou – Innovator in the Field of Proliferative Disease Treatment
Introduction
Xun Zhou, an accomplished inventor based in Carmel, Indiana, has made significant contributions in the pharmaceutical field. He is particularly known for his work at Eli Lilly and Company, where he focuses on developing innovative solutions for treating proliferative diseases.
Latest Patents
Xun Zhou holds one patent titled "Agents and methods for the treatment of proliferative diseases." This patent provides selective kinase inhibitors represented by a specific chemical formula. This groundbreaking work highlights his expertise and contributions to medical advancements.
Career Highlights
As an inventor at Eli Lilly and Company, Xun Zhou has been part of a team dedicated to tackling complex health challenges. His inventive work has the potential to improve therapies for patients suffering from various proliferative diseases, showcasing his commitment to enhancing healthcare through innovation.
Collaborations
Throughout his career, Xun Zhou has collaborated with talented colleagues, including Rima Salim Al-Awar and Kyle Andrew Hecker. Together, they contribute to a dynamic research environment at Eli Lilly and Company, driving forward the development of transformative medical solutions.
Conclusion
Xun Zhou stands out as a dedicated inventor whose work at Eli Lilly and Company represents a significant leap in the treatment of proliferative diseases. His patent on selective kinase inhibitors demonstrates his innovative spirit and positions him as a key contributor to advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile